Cargando…
An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties
We are developing an orally available small-molecule, allosteric TSH receptor (TSHR) agonist for follow-up diagnostics of patients with thyroid cancer. The agonist C2 (NCGC00161870) that we have studied so far is a racemic mixture containing equal amounts of two enantiomers, E1 and E2. As enantiomer...
Autores principales: | Neumann, Susanne, Padia, Umesh, Cullen, Mary Jane, Eliseeva, Elena, Nir, Eshel A., Place, Robert F., Morgan, Sarah J., Gershengorn, Marvin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961696/ https://www.ncbi.nlm.nih.gov/pubmed/27512388 http://dx.doi.org/10.3389/fendo.2016.00105 |
Ejemplares similares
-
Proximity ligation assay to study TSH receptor homodimerization and crosstalk with IGF-1 receptors in human thyroid cells
por: Krieger, Christine C., et al.
Publicado: (2022) -
TSH Receptor Homodimerization in Regulation of cAMP Production in Human Thyrocytes in vitro
por: Boutin, Alisa, et al.
Publicado: (2020) -
Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Morgan, Sarah J., et al.
Publicado: (2016) -
β-Arrestin 1 in Thyrotropin Receptor Signaling in Bone: Studies in Osteoblast-Like Cells
por: Boutin, Alisa, et al.
Publicado: (2020) -
TSH Receptor Signaling Abrogation by a Novel Small Molecule
por: Latif, Rauf, et al.
Publicado: (2016)